- needed]
DMARDs have been
classified as:
synthetic (s
DMARD)
conventional synthetic and
targeted synthetic DMARDs (
csDMARDs and ts
DMARDs, respectively)
csDMARDs...
-
Synthetic Disease-Modifying
Antirheumatic Drugs (
csDMARDs) Who Have an
Inadequate Response to
csDMARDs Alone (SELECT-NEXT)" at ClinicalTrials.gov Clinical...
-
antirheumatic drugs (
DMARDs).
csDMARDs, TNF
biologics and ts
DMARDs are
specific kinds of
DMARDs that are
recommended for treatment.
Treatment with
DMARDs is designed...
- used
medications include NSAIDs, TNF inhibitors, IL-17 antagonists, and
DMARDs.
Glucocorticoid injections are
often used for
acute and
localized flare-ups...
-
antirheumatic drugs (
DMARDs), such as
hydroxychloroquine and methotrexate, may be used to try to slow the
progression of disease.
Biological DMARDs may be used...
-
Immunosuppressive drugs are
categorized into
DMARDs (disease-modifying anti-rheumatic drugs), as well as[clarification needed]
DMARDs can be
further classified into...
- used in the past.[citation needed] Disease-modifying
antirheumatic drugs (
DMARDs) are used
preventively to
reduce the
incidence of flares, the
progress of...
-
symptomatically treated with NSAIDs, disease-modifying
antirheumatic drugs (
DMARDs),
arthroscopic synovectomy, or
physical therapy.
People receiving treatment...
- were
found to be
increased in
rheumatoid arthritis patients responding to
DMARDs or TNF
inhibitor therapy. A low
adiponectin to
leptin ratio has been found...
-
patients treated with
tofacitinib citrate monotherapy or in
combination with
DMARDs) were
upper respiratory tract infections, headache, diarrhea, and nasopharyngitis...
